Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
170Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $27.64M | $-1.04M | $-0.12 |
| 2024 | $26.49M | $-2.16M | $-0.26 |
| 2023 | $17.47M | $-5.77M | $-0.75 |
| 2022 | $18.57M | $-2.49M | $-0.32 |
| 2021 | $19.24M | $-78.3K | $-0.01 |
Social Signal Score
Earnings
Thu, Nov 12(in 3 months)
Consensus estimate $-0.08 per share
Typical surprise +300.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$0.20 vs $0.05beat
- Thu, May 14$0.21 vs $0.05beat
- Wed, Mar 4$-0.31 vs $-0.01miss
Estimates and results for ICCC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
ICCChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (3)
- Newsseekingalpha.com·1d ago·Positive
ImmuCell Corporation (ICCC) Q2 2026 Earnings Call Transcript ImmuCell Corporation (ICCC) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·1d ago·Positive
ImmuCell Q2 Earnings Call Highlights ImmuCell NASDAQ: ICCC reported higher second-quarter sales and earnings as domestic demand for its calf scours prevention products increased, while the company outlined plans to invest about $8 million to more than triple manufacturing capacity by the end of 2027.
View source ↗ - Newsglobenewswire.com·1d ago·Neutral
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026 PORTLAND, Maine, Aug. 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced its unaudited financial results for the quarter ended June 30, 2026.
View source ↗